Mechanistic comparison of pittsburgh compound b unlabelled and Vitamin based on molecular target overlap from BindingDB and ChEMBL binding affinity data.
2
Shared Targets
5%
Jaccard Similarity
5%
IDF-Weighted Similarity
Jaccard measures raw target overlap. IDF-weighted downweights promiscuous hub targets (e.g. CYP enzymes) that bind many compounds non-specifically.
pittsburgh and Vitamin share 2 molecular targets based on binding affinity data from BindingDB (Kd/IC50 ≤ 10 µM) and ChEMBL. A Jaccard index of 0.051 means 5% of the combined target set is bound by both compounds. The IDF-weighted score of 0.051 accounts for non-specific binding to metabolic enzymes.
Note: High target overlap does not imply identical mechanism or therapeutic equivalence. Binding affinity, tissue distribution, bioavailability, and downstream signaling differ significantly between compounds even when they bind the same protein.
Frequently Asked Questions
What do pittsburgh and Vitamin have in common?
pittsburgh and Vitamin share 2 molecular targets with a Jaccard similarity of 5%. Both bind overlapping sets of proteins based on BindingDB and ChEMBL binding affinity data.
Can pittsburgh and Vitamin be combined?
pittsburgh and Vitamin share 2 molecular targets, suggesting potential pathway overlap. Combination use should be evaluated with a qualified healthcare professional. BiohacksAI does not provide medical advice.
Which has more research: pittsburgh or Vitamin?
Both pittsburgh and Vitamin have substantial PubMed research. View their individual profiles for full evidence scores.